Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 248 Jul 28 – Oct 25, 2026
- Disclosed funding
- $6.4B 179 disclosed amounts
- Median round
- $14.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| FH Ferry HealthCompany profile Ferry is an AI healthcare-navigation assistant that helps patients find suitable in-network providers and schedule care. It handles the back-and-forth by checking specialty and location fit, contacting provider offices by phone and completing appointment booking by text; it reaches patients through partnerships with health systems and insurers. Ferry is an AI healthcare-navigation assistant that helps patients find suitable in-network providers and schedule care. It handles the back-and-forth by checking specialty and location fit, contacting provider offices by phone and completing appointment booking by text; it reaches patients through partnerships with health systems and insurers. | $9M | Seed | Healthtech | United States | Investors | |
| JI Josan-she's, Inc.Company profile A maternal-care service connecting families and maternity hospitals with qualified midwives. A maternal-care service connecting families and maternity hospitals with qualified midwives. | ¥400M | Series A | Healthtech | Japan | Investors | |
| RT Retham Technologies, Inc.Company profile Retham is developing HITDx, a functional hospital-lab assay for heparin-induced thrombocytopenia that uses stable cryopreserved donor platelets to make clinically relevant platelet testing more practical; the diagnostic is in validation and regulatory development, while its cryopreserved platelets are available for research use. Retham is developing HITDx, a functional hospital-lab assay for heparin-induced thrombocytopenia that uses stable cryopreserved donor platelets to make clinically relevant platelet testing more practical; the diagnostic is in validation and regulatory development, while its cryopreserved platelets are available for research use. | $1.5M | Seed | Healthtech | United States | Investors | |
| RI ReEmerge, Inc.Company profile ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development. ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development. | $37M | Series A | Healthtech | United States | Investors | |
EvvyCompany profile Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health. Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health. | $40M | Series B | Healthtech | United States | Investors | |
Tandem HealthCompany profile Tandem builds an AI clinical assistant that turns patient consultations and clinician dictation into draft notes and follow-up documents for review in existing medical-record systems. Tandem builds an AI clinical assistant that turns patient consultations and clinician dictation into draft notes and follow-up documents for review in existing medical-record systems. | $100M | Series B | Healthtech | Sweden | Investors | |
| A ArchyCompany profile Cloud software combines dental practice operations and clinical tools with AI agents for routine administrative work. Cloud software combines dental practice operations and clinical tools with AI agents for routine administrative work. | $50M | Series CSeries C+ | Healthtech | United States | Investors | |
AeonCompany profile Preventive health check-ups that combine whole-body MRI, blood biomarkers and medical interpretation to give people a broader view of their health risks. Preventive health check-ups that combine whole-body MRI, blood biomarkers and medical interpretation to give people a broader view of their health risks. | Undisclosed | Seed extensionSeed | Healthtech | Switzerland | Investors | |
AMRA MedicalCompany profile MRI analytics and clinical services that turn medical images into standardized measurements of body fat and muscle for research teams and clinicians. MRI analytics and clinical services that turn medical images into standardized measurements of body fat and muscle for research teams and clinicians. | Undisclosed | InvestmentUndisclosed | Healthtech | Sweden | Investors | |
| KI Kiviaq, Inc.Company profile A pharmacy service combining online prescription handling and medicine delivery with an in-person pharmacist counter. A pharmacy service combining online prescription handling and medicine delivery with an in-person pharmacist counter. | ¥150M | Pre-Series APre-seed | Healthtech | Japan | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 28, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
6rounds1led - 2Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
6rounds2led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
5rounds0led - 4Y Combinator (YC)
Vitalize, Angle Health, Metriport
5rounds0led - 5European Investment Bank
HighLife, MMI, Tensive
5rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.